# Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials

> **NCT03531814** · NA · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 12 (actual)

## Conditions studied

- Neurofibromatosis 1
- Neurofibroma, Plexiform

## Interventions

- **BEHAVIORAL:** Medication Event Monitoring System (MEMS^TM)
- **OTHER:** Questionnaires

## Key facts

- **NCT ID:** NCT03531814
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-23
- **Primary completion:** 2023-03-20
- **Final completion:** 2023-03-20
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03531814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03531814, "Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT03531814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*